Abstract
Autologous stem cell transplantation (ASCT) is an established treatment for patients with hematologic malignancies. The minimum CD34+ cell dose needed to ensure hematopoietic recovery following ASCT is 2x106 cells/kg. The aim of this paper is to prove that absolute number of cells (ANC) CD34+>=20,01x106/L in the peripheral blood is confirmation of successful collection. The study was a retrospective-prospective. We analysed 44 patients Myeloma Multiplex 23(33.3%), Hodgkin lymphoma 29 (42.0%), non-Hodgkin Lymphoma 17 (24.6%) with 69 apheresis conducted in the process of autologous stem cell transplantation at Haematology clinic KCUS in the period from April 2013 to October 2016. Patients were divided into two groups: collection of CD34+<2.0x106/kgand>=2.0x106/kgin one day.Independent variables analyzed were: CD34+cell dose in peripheral blood in one collection, age, gender and diagnosis. The average age of patients was 45 ± 16.03 years. Youngest patient was 18 and the oldest was 67 years. There were 52.3% male patients and 47.7% female.Collection of CD34+ <2.0x106/kg occurred in 20 (27.5%) cases and 49 (72.5%) had CD34+≥ 2.0. In the group with CD34+ ≥2.0x106/kg there were 91.8% with ANC CD34+ ≥20.01 x106 /l in peripheral blood. Only three collections of CD34+ >=2.0x106/kg had values in peripheral blood ANC CD34 + from 15.01 to 20.00x106 /l and only one collection ANC CD34+ between 10.01 and 15.00 x106 /l. Displayed difference is statistically significant p=0.0001. We used the c2 test, Kolmogorov Smirnov and Mann-Whitney U test. P<0.05 was considered significant. Successful collection is guaranteed at ANC CD34+ >= 20.01 x 106/L in the peripheral blood.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Child JA, Morgan GJ, Davies FE, et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med. 2003;348:1875–1883.
Bonfante V, Santoro A, Viviani S, Devizzi L, Balzarotti M, Soncini F, et al. Outcome of patients with Hodgkin’s disease failing after primary MOPP-ABVD. J Clin Oncol 1997;15(2): 528–34.
Shea TC, DiPersio JF. Mobilization of autologous peripheral blood hematopoietic cells for cellular therapy. In: Applebaum FR, Forman SJ, Negrin RS, Blume KG, eds . Thomas’ Hematopoietic Cell Transplantation . Hoboken, NJ: Wiley-Blackwell; 2009:590-604 .
Giralt S, Stadtmauer EA, Harousseau JL, et al . International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100) Leukemia. 2009;Jun 25 [epub ahead of print] .
Awan F.T, Kochuparambil S.T, DeRemer D, Cumpston A, Craig M, Jillella A, Hamadani M. Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell Mobilization. J Oncol 2012, Article ID 931071, 5 pages doi:10.1155/2012/931071
Shea TC, DiPersio JF. Mobilization of autologous peripheral blood hematopoietic cells for cellular therapy. In: Applebaum FR, Forman SJ, Negrin RS, Blume KG, eds . Thomas’ Hematopoietic Cell Transplantation . Hoboken, NJ: Wiley-Blackwell; 2009:590-604 .
Ilhami B, Mehmet AE, Irfan K. DHAP plus filgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation In patients with relapsed/refractory. Mustafa Ozgul lymphoma: a single center experience. Abstract.January 2016
Flinn IW, O’Donnell PV, Goodrich A, et al . Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin’s lymphoma . Biol Blood Marrow Transplant. 2000;6(6):628-632 .
Naparstek E . The role of the anti-CD20 antibody rituximab in hematopoietic stem cell transplantation for non-Hodgkin’s lymphoma . Curr Hematol Rep. 2005;4(4):276283.
Kim J.E, Yoo C, Kim S, Lee D.H, Kim S, Lee J.S, Suh C. Optimal timing of G-CSF administration for effective autologous stem cell collection. Bone Marrow Trasplant 2011; 46: 806-812.
Basquiera AL, Abichain P, Damonte JC, et al . The number of CD34(+) cells in peripheral blood as a predictor of the CD34(+) yield in patients going to autologous stem cell transplantation . J Clin Apher. 2006;21(2):92-95 .
Cassens U, Barth IM, Baumann C, et al . Factors affecting the efficacy of peripheral blood progenitor cells collections by large-volume leukaphereses with standardized processing volumes . Transfusion. 2004;44(11):1593-1602 .
Nemet D, Sertić D, Radman I, Kovačević Metelko J, Bogdanić V, Bojanić V. Napredak u liječenju multiplog mijeloma. Liječnički Vjesnik Suppl 1, 2012.
Greivin Zumbado-Sala, Miguel Rodríguez-Pineda, Xinia Rojas-Camacho, Carlos Rojas-Solano y Hever Herrera-Álvarez. Recolección de células madre en sangre periférica mediante aféresis de grandes volúmenesPeripheral blood stem cell collection by apheresis Acta méd. costarric vol.56 n.2 San José Apr./Jun. 2014
Hosing C, Saliba RM, Hamerschlak N, Kutner JM, Sakashita AM, Kondo AT et al. Peripheral blood stem cell yield calculated using preapheresis absolute CD34+ cell count, peripheral blood volume processed, and donor body weight accurately predicts actual yield at multiple centers. 2014 Apr;54(4):1081-7. doi: 10.1111/trf.12435. Epub 2013 Oct 9.
Jillella AP, Ustun C. What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant? 2004 Dec;13(6):598-606.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Sofo-Hafizovic, A. et al. (2017). Successful collection of stem cells in one day in the process of autologous stem cell transplantation. In: Badnjevic, A. (eds) CMBEBIH 2017. IFMBE Proceedings, vol 62. Springer, Singapore. https://doi.org/10.1007/978-981-10-4166-2_120
Download citation
DOI: https://doi.org/10.1007/978-981-10-4166-2_120
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-4165-5
Online ISBN: 978-981-10-4166-2
eBook Packages: EngineeringEngineering (R0)